FTY720, a novel immunosuppressant possessing unique mechanisms. I. Prolongation of skin allograft survival and synergistic effect in combination with cyclosporine in rats

Transplantation Proceedings

Volumn 28, Issue 2, 1996, Pages 1056-1059

  Chiba, K ^a   Hoshino, Y ^a   Suzuki, C ^a   Masubuchi, Y ^a   Yanagawa, Y ^a   Ohtsuki, M ^a   Sasaki, S ^a   Fujita, T ^a  

^a Yoshitomi Pharmaceutical Industries Ltd   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; FINGOLIMOD; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2;

ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG POTENTIATION; FULL THICKNESS SKIN GRAFT; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SKIN ALLOGRAFT; SPLEEN CELL;

ANIMALS; CYCLOSPORINE; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; PROPYLENE GLYCOLS; RATS; RATS, INBRED F344; RATS, INBRED LEW; RATS, INBRED STRAINS; SKIN TRANSPLANTATION; SPHINGOSINE; SPLEEN; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 0029996293     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)